A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors

NCT05672459 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Single Injection of IVS-3001- Anti - HLA-G CAR-T cells
DRUG: Fludarabine phosphate
DRUG: Cyclophosphamide
PROCEDURE: leukapheresis

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]